Factors regarding increase of platelet counts in chronic hepatitis C patients with sustained virological response to interferon : Relation to serum thrombopoietin levels
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-11-01
著者
-
Kojima H
Department Of Gastroenterology National Tokyo Hospital
-
YAGURA Michiyasu
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
TANAKA Akihisa
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
TOKITA Hajime
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
KAMITSUKASA Hiroshi
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
HARADA Hideharu
Department of Gastroenterology, National Hospital Organization Tokyo Hospital
-
Yagura Michiyasu
Department Of Gastroenterology National Tokyo Hospital
-
Tawara Akio
First Department Of Internal Medicine Yamanashi Medical University
-
Tokita Hajime
Department Of Gastroenterology National Tokyo Hospital
-
Harada Hideharu
Department Of Gastroenterology National Tokyo Hospital
関連論文
- Re-evaluation of the Serum Alanine Aminotransferase Upper Normal Limit in Chronic Hepatitis C Patients
- Factors regarding increase of platelet counts in chronic hepatitis C patients with sustained virological response to interferon : Relation to serum thrombopoietin levels
- Circulating KL-6 level at baseline is a predictive indicator for the occurrence of interstitial pneumonia during interferon treatment for chronic hepatitis C
- TT virus of certain genotypes may reduce the platelet count in patients who achieve a sustained virologic response to interferon treatment for chronic hepatitis C
- Influence of TT virus infection on the thrombocytopenia of patients with chronic liver disease
- Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease
- Influence of TT virus on the clinical course of alcoholic liver disease
- Does the control of alanine aminotransferase levels lead to a regression of liver fibrosis in chronic hepatitis C patients?
- Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-α therapy: including quantitative assessment by a morphometric method
- Parameters predicting response to ursodeoxycholic acid therapy in chronic hepatitis C
- Persistence of hepatitis B viremia after recovery from acute hepatitis B : correlation between anti-HBc titer and HBV DNA in serum
- Treatment of chronic hepatitis C patients with amantadine
- Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis